Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,24945,877,1.27 [1.14-1.42],2.3585389334443013e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24971,132,1.57 [1.22-2.04],0.0005611244069645
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19830,479,1.47 [1.28-1.70],1.0562537867224969e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27522,65,1.53 [1.06-2.23],0.0240803297337605
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26677,383,1.48 [1.26-1.74],1.1335319987447423e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26438,144,1.62 [1.26-2.08],0.0001559038779534
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26540,246,1.45 [1.19-1.77],0.0002106742223377
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23997,126,1.35 [1.01-1.80],0.0437862578211443
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24002,131,1.41 [1.07-1.87],0.0153323340426659
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",23920,49,1.84 [1.24-2.72],0.0024500010565462
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter II Neoplasms,Benign lipomatous neoplasm,27334,290,1.27 [1.05-1.54],0.0148587708693692
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),25326,348,1.35 [1.14-1.60],0.0006358987063483
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,24240,688,1.30 [1.15-1.48],4.1838540115392286e-05
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26342,432,1.22 [1.04-1.44],0.0155677173314547
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,25863,114,0.58 [0.41-0.84],0.00411520654948
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25848,99,0.65 [0.44-0.96],0.0302037179264008
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24079,527,1.23 [1.06-1.42],0.0059476310554555
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,24035,483,1.23 [1.05-1.43],0.0101636783773956
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23630,78,1.58 [1.12-2.23],0.0091823358332758
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Any mental disorder,23976,754,1.41 [1.26-1.58],4.238188135056625e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23512,290,1.49 [1.26-1.77],2.69673466593303e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Alcohol dependence,25687,95,1.46 [1.11-1.92],0.0068640403995997
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Smoking dependency,25653,66,2.04 [1.50-2.78],6.494614514498436e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23293,71,1.48 [1.06-2.07],0.0225816627511024
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",23605,383,1.51 [1.29-1.77],2.2979338649368494e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Depression,25932,332,1.47 [1.25-1.73],4.6382852160915125e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter V Mental and behavioural disorders,Depression or dysthymia,23455,289,1.55 [1.30-1.85],1.3924304032866892e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter VI Diseases of the nervous system,Neurological diseases,24594,1430,1.12 [1.02-1.23],0.0152088505372922
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21651,1944,1.14 [1.05-1.24],0.0022152313156299
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26149,563,1.38 [1.20-1.58],4.065302351377453e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Angina pectoris,25933,347,1.32 [1.11-1.57],0.0015334619258309
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26932,135,1.39 [1.07-1.80],0.0149563207958805
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27053,256,1.46 [1.20-1.76],0.0001132753336316
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25742,156,1.60 [1.26-2.04],0.0001232030893744
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,25994,418,1.34 [1.15-1.57],0.0002212845588463
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,25048,40,1.75 [1.09-2.82],0.0216990548225697
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26950,83,1.51 [1.10-2.07],0.0118273709779997
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,23406,1902,1.26 [1.17-1.37],9.301949013885748e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26459,184,1.63 [1.31-2.02],1.2347393377187057e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26433,158,1.77 [1.41-2.23],8.170427045432864e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27044,207,1.54 [1.26-1.89],3.010139872167749e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27042,205,1.55 [1.26-1.90],3.1101115444834125e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Nasal polyp,26219,108,0.66 [0.46-0.95],0.0247652633886719
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,25311,856,1.16 [1.04-1.30],0.0108555981118219
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Asthma,21172,779,1.24 [1.09-1.40],0.0010067156118395
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21033,779,1.24 [1.09-1.41],0.0008804836150765
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21157,764,1.25 [1.10-1.42],0.0004891914817326
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27454,55,3.48 [2.62-4.62],5.579968497405224e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,26334,42,3.96 [2.91-5.38],1.8865811654846146e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",27514,42,3.92 [2.89-5.32],2.026967865132e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26327,35,3.52 [2.45-5.06],8.964238416804704e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,26424,177,1.56 [1.24-1.95],0.0001394053464747
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",23753,1718,1.12 [1.03-1.22],0.0082453074883401
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,22582,547,1.17 [1.01-1.35],0.0312917144450547
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Umbilical hernia,23877,118,0.62 [0.44-0.88],0.0071261652783317
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26140,115,0.68 [0.48-0.97],0.0331920562301394
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,21285,174,1.42 [1.12-1.80],0.0035985581130869
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27226,83,1.62 [1.16-2.26],0.004282229312631
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27214,71,1.62 [1.13-2.33],0.0094121767293308
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26395,275,1.28 [1.06-1.55],0.009454926616019
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26185,65,1.46 [1.00-2.14],0.0473395576896349
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Coeliac disease,26171,51,1.76 [1.19-2.61],0.0046776404230152
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26296,176,1.27 [1.01-1.60],0.0427248833711991
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26542,528,1.19 [1.03-1.37],0.020026715686906
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26223,209,1.26 [1.01-1.57],0.0449928761777253
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26194,180,1.28 [1.01-1.62],0.0417639831276769
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21400,3454,1.18 [1.10-1.25],7.216626021650528e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22990,1825,1.14 [1.05-1.24],0.0019471242110941
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25234,1093,1.21 [1.09-1.34],0.0003651998845592
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,22378,1213,1.15 [1.04-1.27],0.0056222831295751
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21333,168,1.29 [1.00-1.67],0.0494583749872512
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,21884,277,1.43 [1.18-1.73],0.0002421133784183
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27251,151,1.38 [1.06-1.78],0.0154538318298136
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27139,39,2.07 [1.36-3.17],0.0007627763884105
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,24720,49,1.63 [1.07-2.48],0.0236920270882775
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,25555,884,1.26 [1.13-1.41],3.116560981977521e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25415,744,1.28 [1.14-1.45],4.363263867571223e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,24729,58,1.57 [1.06-2.34],0.0243595059598385
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,24738,67,1.63 [1.12-2.37],0.0101224764624598
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,24817,146,1.44 [1.12-1.87],0.0049960559735742
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24988,317,1.44 [1.21-1.71],4.250584027597883e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24365,224,1.31 [1.05-1.63],0.0165707587918023
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24249,108,1.47 [1.08-1.99],0.0136016614127784
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24564,423,1.24 [1.06-1.46],0.0076624298112033
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24357,216,1.35 [1.09-1.67],0.006699742457118
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,26512,335,1.25 [1.05-1.49],0.0137212610456589
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23345,4326,1.10 [1.04-1.17],0.0012038874355752
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26279,43,1.82 [1.19-2.78],0.0055589333796248
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27190,162,1.36 [1.06-1.75],0.0160928965125934
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26127,863,1.17 [1.04-1.32],0.0072670938518123
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25871,607,1.20 [1.05-1.37],0.0095234898413783
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15076,381,1.38 [1.17-1.63],0.0001632497916134
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,14883,188,1.63 [1.31-2.03],1.4517162511423098e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Endometriosis,11454,296,1.22 [1.00-1.48],0.048002711575297
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11271,113,1.46 [1.08-1.96],0.0131248479136831
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,11296,138,1.33 [1.01-1.75],0.0390947044348247
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",15261,198,1.26 [1.00-1.59],0.0482985662619743
SFTPA2,Pulmonary surfactant-associated protein A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11230,72,1.49 [1.04-2.14],0.0313668876960889
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",15268,155,1.32 [1.01-1.71],0.0394270363764193
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,15281,863,0.83 [0.73-0.96],0.008913920158699
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,15287,1171,0.76 [0.67-0.86],1.7739881969532008e-05
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,14567,149,0.63 [0.46-0.87],0.0046936219106557
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,14343,227,0.74 [0.57-0.96],0.0238313713068384
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],14539,423,0.75 [0.62-0.91],0.0034429549515649
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,14766,650,0.79 [0.67-0.93],0.003712340853918
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",15304,165,0.74 [0.54-0.99],0.0458748602129722
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,13876,126,0.69 [0.49-0.97],0.0336167765137729
SFTPA2,Pulmonary surfactant-associated protein A2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,15311,332,0.80 [0.65-0.99],0.0400569655770214
